Navigation Links
Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB
Date:5/6/2009

STOCKHOLM, May 6 /PRNewswire/ -- Axelar AB today announced successful completion of the single-day oral dosing part of its ongoing phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717,an insulin-like growth factor-1 (IGF-1) receptor inhibitor which has no effects on the closely related insulin receptor. The study is conducted in Sweden on patients having terminal cancer disease. The results showed that a single-day dosing of AXL1717 could be successfully escalated with excellent tolerability. No dose-limiting toxicity was reported. The next part of the trial has now been approved, including a seven-day dosing BID regimen instead of single-day BID treatments. The first patients have already been treated with AXL1717 for seven days.

The ongoing phase I/II clinical trial is primarily designed to assess the safety, tolerability, and pharmacokinetics of the drug. As a secondary objective, anti-cancer effects are documented whenever possible.

"We are very pleased that high doses of AXL1717 could be administered to patients without significant side effects during the single-day treatments.", says Johan Harmenberg, CEO of Axelar AB. "Targeting cancer cells with AXL1717 instead of conventional cytotoxic chemotherapy may be a new and well-tolerated treatment alternative for cancer patients in the future."

The IGF-1 receptor is a promising target for the treatment of cancer, since the receptor is crucial for the survival and growth of malignant cells. In contrast, the IGF-1 receptor is not absolutely necessary for growth of normal cells.

AXL1717 is a small-molecule IGF-1 receptor inhibitor with no effect on the important and almost identical insulin receptor. Pre-clinical data show an extraordinary anti-tumor efficacy in animal models, including apparent complete tumor regression, for a wide range of human cancers such as breast cancer, prostate cancer, malig
'/>"/>

SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related biology technology :

1. Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
3. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
4. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
5. EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology
6. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Indevus Pharmaceuticals and Announces Subsequent Offering Period
7. DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
8. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
9. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
10. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
11. Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , SHANGHAI, Dec. 1 /PRNewswire-Asia/ --...of ShangPharma, a leading China-based Contract Res...winner of the 2009 Deloitte,Technology Fast 50 Chi... high,tech companies in China. The award is a test...nue growth from 2006 to 2008. , The resul...
(Date:12/1/2009)... , SPRINGFIELD, Ill., Dec. 1 /PRNewswire/ ...proud to announce that it was recently awarded two...ds event on Nov. 13 in New York City. The CLIO Hea...innovation in the healthcare advertising industry ... world,s most recognized awards competitions for a...
(Date:12/1/2009)... Enterprise level storage is ...e providers without breaking the bank. , ...ive, LLC. ( www.pacsdrive.com ), a medical imagi...w DICOM compatible cloud storage service. The Pacs...h care providers to securely archive medical imagi...
(Date:12/1/2009)... Congruent Software agrees to...uding project accounting clients) to Synergy Busin... Seattle, WA (PRWEB) December 1...ay it has acquired the Microsoft Dynamics SL pract... technology provider. The move was necessary due t...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3
...onse Genetics,Inc. (Nasdaq: RGDX ), today announc... provide a business overview at the following inve...nual Growth Conference at the St. Regis,Hotel in S...m. PDT. -- Maxim Group,s 1st Annual Growth Confer...Thursday, September 20th at 3:30 p.m. EDT. Both p...
...Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ...ll Lynch Global Pharmaceutical, Biotech and Medtec...sed by visiting the Investors section,of the Compa... http://www.newscom.com/cgi-bin/prnh/19991220/MLN...w of the Company, an update on,clinical trials for...
...lon, Inc. (Nasdaq:,CEPH) today communicated with h... patient selection, dosing and administration for ...mpany is sharing this information,with the medical...g and use,of the medication. The letter, issued i...stration (FDA), was in response to recently report...
Other Biology Technology:Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences 2Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation 2Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 2Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 3Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 4Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA 5
(Date:11/30/2009)...om The Forsyth Institute, the University of Connec...ter, have used state-of-the-art technology to eluc...idum, the bacterium which causes syphilis. The pre... can now be shown in three dimensions. This provid...s previously unknown features, which may help figh...
(Date:11/30/2009)...ble in German . , The DFG has approved the ...tres as of 1 January 2010. This decision was made ... The new centres will initially be funded for four...0 percent overhead funding for indirect costs will...esearch topics range from modern prostheses to pol...
(Date:11/30/2009)... Scientists and engineers from two of the nation,...me together Dec. 7 with leading academicians to ex...d. , Much like moving oil through a pipeline, th...stems need clean, well-functioning pipes (or blood...tion efficiently. Both industries also are crucial...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3New research identifies more effective tools for detection of colorectal cancer 47489 1New research identifies more effective tools for detection of colorectal cancer 47489 2New research identifies more effective tools for detection of colorectal cancer 47489 3New research identifies more effective tools for detection of colorectal cancer 47489 4New research identifies more effective tools for detection of colorectal cancer 47489 5New research identifies more effective tools for detection of colorectal cancer 47489 6New research identifies more effective tools for detection of colorectal cancer 47489 717 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2Newly discovered reactions from an old drug may lead to new antibiotics 8679 1Newly discovered reactions from an old drug may lead to new antibiotics 8679 2
...e world stand to benefit from a new research centr...o develop more advanced fertilizers for agricultur...logy Research Centre, to be based at the Universit...d-leading scientists and facilities. , The new ce...laide in a joint commercial venture with one of th...
...d modern birds originate around the time of the di...er" , The question is at the center of a sometim...n paleontologists, whose estimates are based on th... clock" methods to study evolutionary history. , ... Michigan, the University of Chicago, the Centre f...
...of the Integrated Ocean Drilling Programs Nankai T...mpleted its mission off the Kii Peninsula today. T...nting 10 countries, set forth on Dec. 19, 2007, ab...eformation, structural partitioning, and physical ...he expedition was led by co-chief scientists Eliza...
Other Biology News:Fertilizer research center an Australian first 2Avian origins: new analysis confirms ancient beginnings 2Scientists obtain core samples from subsea fault system off Japan 2
BD BioCoat Gelatin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
BD Falcon Standard Cell Culture Dish from BD Biosciences - Discovery Labware
BD BioCoat Laminin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: